Michael J Haller
Overview
Explore the profile of Michael J Haller including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
181
Citations
3464
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Phillip M, Achenbach P, Addala A, Albanese-ONeill A, Battelino T, Bell K, et al.
Diabetologia
. 2025 Feb;
PMID: 39934371
No abstract available.
2.
Foster T, Bruggeman B, Haller M
Drugs
. 2025 Jan;
PMID: 39873914
Type 1 diabetes mellitus (T1DM) is characterized by the progressive, autoimmune-mediated destruction of β cells. As such, restoring immunoregulation early in the disease course is sought to retain endogenous insulin...
3.
Williams M, Grace C, Posgai A, McGrail K, Brusko M, Haller M, et al.
BMJ Open Diabetes Res Care
. 2025 Jan;
13(1.
PMID: 39755561
Introduction: Altered serum levels of growth hormones, adipokines, and exocrine pancreas enzymes have been individually linked with type 1 diabetes (T1D). We collectively evaluated seven such biomarkers, combined with islet...
4.
Walker A, Haller M, Addala A, Filipp S, Lal R, Gurka M, et al.
Diabetes Care
. 2024 Dec;
48(2):243-250.
PMID: 39688288
Objective: The Project Extension for Community Healthcare Outcomes (ECHO) model is used in 180 countries to address chronic disease care through a provider empowerment, tele-education approach. Few studies have rigorously...
5.
Bruggeman B, Gornisiewicz S, Bacher R, McGrail K, Campbell-Thompson M, Wasserfall C, et al.
Front Endocrinol (Lausanne)
. 2024 Dec;
15:1497373.
PMID: 39678192
Introduction: The immune-mediated destruction of insulin-producing β-cells characterizes type 1 diabetes. Nevertheless, exocrine pancreatic enzymes, including amylase, lipase, and trypsin, are also significantly reduced in type 1 diabetes. With an...
6.
Haller M, Bell K, Besser R, Casteels K, Couper J, Craig M, et al.
Horm Res Paediatr
. 2024 Dec;
97(6):529-545.
PMID: 39662065
The International Society for Pediatric and Adolescent Diabetes (ISPAD) guidelines represent a rich repository that serves as the only comprehensive set of clinical recommendations for children, adolescents, and young adults...
7.
Lernmark A, Agardh D, Akolkar B, Gesualdo P, Hagopian W, Haller M, et al.
Nat Rev Endocrinol
. 2024 Nov;
21(3):154-165.
PMID: 39496810
The goal of the TEDDY (The Environmental Determinants of Diabetes in the Young) study is to elucidate factors leading to the initiation of islet autoimmunity (first primary outcome) and those...
8.
Li P, Spector E, Alkhuzam K, Patel R, Donahoo W, Bost S, et al.
Diabetes Obes Metab
. 2024 Sep;
27(1):102-110.
PMID: 39344840
Aim: To develop an automated computable phenotype (CP) algorithm for identifying diabetes cases in children and adolescents using electronic health records (EHRs) from the UF Health System. Materials And Methods:...
9.
Christopher M, Veigle O, Lloyd S, Mcgrail S, Lee J, Bazargani S, et al.
Diabetes Care
. 2024 Sep;
47(12):e104-e105.
PMID: 39316384
No abstract available.
10.
Walker A, Haller M, Addala A, Filipp S, Lal R, Gurka M, et al.
BMJ Open Diabetes Res Care
. 2024 Sep;
12(4).
PMID: 39242122
Introduction: Diabetes disparities exist based on socioeconomic status, race, and ethnicity. The aim of this study is to compare two cohorts with diabetes from California and Florida to better elucidate...